A Study to Evaluate the Soluble Guanylate Cyclase (sGC) Stimulator IW-1973 in Diabetic Nephropathy / Diabetic Kidney Disease as Measured by Albuminuria

Completed · Phase 2 · Has a placebo group

Conditions studied: Type 2 Diabetes Mellitus With Diabetic Nephropathy

In brief

To evaluate the safety and efficacy of IW-1973 in patients with type 2 diabetes mellitus with albuminuria who are on a stable regimen of renin-angiotensin system inhibitors.

Key facts

Study ID
NCT03217591
Run by
Akebia Therapeutics
People needed
156
Starts
2017-08-01
Expected to finish
2019-08-20
Last updated by the study team
2022-09-15

Who can join

Age: 25 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.